Nanobiotix S.A. (NBTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nanobiotix S.A.

    NASDAQ: NBTX · Real-Time Price · USD
    20.51
    0.63 (3.17%)
    At close: Oct 03, 2025, 3:58 PM
    20.51
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    Nanobiotix S.A. Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 -11.61M 36.21M 4.78M 2.65M
    Cost of Revenue
    		 n/a n/a 985K n/a
    Gross Profit
    		 -11.61M 36.21M 3.79M 2.65M
    Operating Income
    		 -68.39M -26.78M -46.7M -52.58M
    Interest Income
    		 2.63M 1.22M 256K 6.17M
    Pretax Income
    		 -68.03M -39.58M -57.03M -47M
    Net Income
    		 -68.13M -39.7M -57.04M -47M
    Selling & General & Admin
    		 20.06M 22.05M 17.48M 19.43M
    Research & Development
    		 40.54M 38.4M 32.64M 30.38M
    Other Expenses
    		 -3.82M 2.54M 1.36M 5.41M
    Operating Expenses
    		 56.78M 62.99M 51.48M 55.23M
    Interest Expense
    		 8.09M 7.98M 5.84M 671K
    Selling & Marketing Expenses
    		 n/a 388K n/a n/a
    Cost & Expenses
    		 56.78M 62.99M 51.48M 55.23M
    Income Tax Expense
    		 101K 120K 10K 5K
    Shares Outstanding (Basic)
    		 47.27M 36.76M 34.85M 34.73M
    Shares Outstanding (Diluted)
    		 47.27M 36.93M 34.85M 34.73M
    EPS (Basic)
    		 -1.44 -1.08 -1.64 -1.35
    EPS (Diluted)
    		 -1.44 -1.08 -1.64 -1.35
    EBITDA
    		 -58.32M -23.69M -44.22M -45.6M
    EBIT
    		 -59.95M -24.24M -45.72M -47.16M
    Depreciation & Amortization
    		 1.62M 551K 1.5M 1.56M

    Add to Watchlist